SMARCB1 and congenital mesoblastic nephroma: In RTK and CMN, molecular markers, i.e., loss of SMARCB1 expression and ETV6-NTRK3 fusion, respectively, are useful for an ancillary diagnosis, whereas the diagnosis of nephroblastoma and CCSK is exclusively based on histologic features.